Trial Profile
The Investigation of the Impact of Atypical Antipsychotics on Brain Functioning in Youths With Conduct Disorder
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone (Primary)
- Indications Conduct disorder
- Focus Pharmacodynamics
- 19 May 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 20 Jun 2013 New trial record